- Home
- REPL vs IIIN Comparison
REPL vs IIIN Comparison
Compare REPL & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- IIIN
- Stock Information
- Founded
- REPL 2015
- IIIN 1953
- Country
- REPL United States
- IIIN United States
- Employees
- REPL N/A
- IIIN N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- IIIN Steel/Iron Ore
- Sector
- REPL Health Care
- IIIN Industrials
- Exchange
- REPL Nasdaq
- IIIN Nasdaq
- Market Cap
- REPL 757.8M
- IIIN 704.8M
- IPO Year
- REPL 2018
- IIIN N/A
- Fundamental
- Price
- REPL $9.21
- IIIN $38.06
- Analyst Decision
- REPL Strong Buy
- IIIN
- Analyst Count
- REPL 7
- IIIN 0
- Target Price
- REPL $20.83
- IIIN N/A
- AVG Volume (30 Days)
- REPL 1.1M
- IIIN 126.2K
- Earning Date
- REPL 08-07-2025
- IIIN 07-17-2025
- Dividend Yield
- REPL N/A
- IIIN 3.01%
- EPS Growth
- REPL N/A
- IIIN N/A
- EPS
- REPL N/A
- IIIN 1.16
- Revenue
- REPL N/A
- IIIN $570,455,000.00
- Revenue This Year
- REPL N/A
- IIIN $22.06
- Revenue Next Year
- REPL N/A
- IIIN $6.70
- P/E Ratio
- REPL N/A
- IIIN $32.18
- Revenue Growth
- REPL N/A
- IIIN N/A
- 52 Week Low
- REPL $6.44
- IIIN $22.49
- 52 Week High
- REPL $17.00
- IIIN $38.58
- Technical
- Relative Strength Index (RSI)
- REPL 53.47
- IIIN 60.41
- Support Level
- REPL $9.15
- IIIN $36.00
- Resistance Level
- REPL $9.64
- IIIN $37.98
- Average True Range (ATR)
- REPL 0.50
- IIIN 0.82
- MACD
- REPL -0.06
- IIIN 0.13
- Stochastic Oscillator
- REPL 50.57
- IIIN 73.78
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.